Beijing Tong Ren Tang Chinese Medicine Company Limited announced unaudited consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported revenue of HKD 759,533,000 compared to HKD 623,775,000 a year ago. Operating profit was HKD 377,706,000 compared to HKD 315,228,000 a year ago. Profit before income tax was HKD 384,287,000 compared to HKD 321,042,000 a year ago. Profit attributable to owners of the company was HKD 307,505,000 or HKD 0.37 per basic and diluted share compared to HKD 257,349,000 or HKD 0.31 per basic and diluted share a year ago. Net cash generated from operating activities was HKD 286,729,000 compared to HKD 249,054,000 a year ago. Purchase of property, plant and equipment was HKD 41,847,000 compared to HKD 18,907,000 a year ago. Deposit paid for purchase of property, plant and equipment was HKD 3,010,000 compared to HKD 697,000 a year ago. During the Period, the group's capital expenditure was HKD 44.3 million against HKD 19.2 million a year ago, which was mainly used for the establishment of new retail outlets and purchase of a property for operation purpose.